A common characteristic of malignant cells derived from patients with Hodgkin's disease (HD) is a high level of constitutive nuclear NF-kB/Rel activity, which stimulates proliferation and confers resistance to apoptosis. We have analysed the mechanisms that account for NF-kB activation in a panel of Hodgkin/Reed-Sternberg (H-RS) cell lines. Whereas two cell lines (L428 and KMH-2) expressed inactive IkBa, no signi®cant changes in NF-kB or IkB expression were seen in other H-RS cells (L591, L1236 and HDLM-2). Constitutive NF-kB was susceptible to inhibition by recombinant IkBa, suggesting that neither mutations in the NF-kB genes nor posttranslational modi®cations of NF-kB were involved. Endogenous IkBa was bound to p65 and displayed a very short half-life. IkBa degradation could be blocked by inhibitors of the NF-kB activating pathway. Proteasomal inhibition caused an accumulation of phosphorylated IkBa and a reduction of NF-kB activity in HDLM-2 and L1236 cells. By in vitro kinase assays we demonstrate constitutive IkB kinase (IKK) activity in H-RS cells, indicating ongoing signal transduction. Furthermore, H-RS cells secrete one or more factor(s) that were able to trigger NF-kB activation. We conclude that aberrant activation of IKK's, and in some cases defective IkBs, lead to constitutive nuclear NF-kB activity, which in turn results in a growth advantage of Hodgkin's disease tumor cells.
Introduction
Hodgkin's disease (HD) is characterized by mononuclear Hodgkin (H) cells and multinucleated ReedSternberg (RS) cells that represent only a small fraction of the cellular populations in the aected lymph nodes. These malignant cells are distributed on a hyperplastic background of reactive lymphocytes, plasma cells, eosinophiles, histiocytes, and stromal cells. Hodgkin/ Reed-Sternberg (H-RS) cells produce a variety of cytokines, growth factors and cell surface receptors and many of the histopathological and clinical features correlate well with deregulated cytokine expression (Hsu et al., 1994) . Analysis of genotype and surface marker expression has revealed that H-RS cells most often carry characteristics of lymphoid origin (reviewed in Kaufman et al., 1992; Hsu et al., 1994; . The availability of several H-RS cell lines, mostly derived from pleural eusions, has allowed a detailed molecular analysis. In one case it could be demonstrated by single cell PCR analysis of Ig gene rearrangements that the peripheral blood-derived cell line L1236 is clonally identical with H-RS cells in tissue-sections of the patient .
Recently, we have discovered characteristic nuclear DNA binding activities consisting of Oct-2 and various NF-kB/Rel proteins in H-RS cells. An aberrant constitutive activity of the inducible transcription factor NF-kB has been found in all Hodgkin derived cell lines tested so far. Furthermore, constitutive NFkB has been detected in primary H-RS cells from a pleural eusion as well as in H-RS cells in lymph node sections (Bargou et al., 1996 (Bargou et al., , 1997 .
NF-kB/Rel transcription factors mediate the expression of numerous genes involved in diverse functions such as in¯ammation, immune response, apoptosis and cell proliferation (Siebenlist et al., 1994; Wulczyn et al., 1996; May and Ghosh, 1997; Sonenshein, 1997; Luque and Gelinas, 1997) . The mammalian NF-kB/Rel family comprises ®ve members (p50, p52, p65(RelA), c-Rel and RelB) which form various homo-and heterodimers and are tightly regulated by a group of IkB proteins (IkBa, IkBb, IkBe, p105, . In unstimulated cells, NF-kB is sequestered in the cytoplasm by IkBa, IkBb or IkBe, which upon stimulation with various inducers (e.g. cytokines, mitogens or pathogens), are rapidly degraded. Liberated NF-kB subsequently translocates to the nucleus and activates transcription. The mechanism for signal induced activation is best characterized for cytoplasmic NF-kB/IkBa complexes. Phosphorylation of IkBa at serines 32 and 36 targets the protein for ubiquitination at lysines 21 and 22 leading to a complete destruction by the proteasome (Palombella et al., 1994; Baldi et al., 1995; Brockman et al., 1995; Brown et al., 1995; Chen et al., 1995; Scherer et al., 1995; Traenckner et al., 1995; Whiteside et al., 1995; DiDonato et al., 1996; Ro et al., 1996; Rodriguez et al., 1996) . A complex containing two protein kinases (IKKa and IKKb) has been identi®ed which is responsible for phosphorylation of IkBa and subsequent activation of NF-kB in response to cytokines (reviewed in Stancovsci and Baltimore, 1997; Maniatis, 1997) . Besides the inducible but transient activation, constitutive nuclear NF-kB has been observed in some cell types including mature B cells, plasma cells, certain neurons (Sen and Baltimore, 1986; Kaltschmidt et al., 1994) as well as in speci®c tissues (e.g. thymus, bone marrow, spleen, cortex) of adult mice (Schmidt-Ullrich et al., 1996) . As a mechanism for constitutive NF-kB activity in B cells, an enhanced turnover of IkBa has been proposed (Rice and Ernst, 1993; Miyamoto et al., 1994) , which could either be driven by proteasomal degradation that is independent of N-terminal phosphorylation and ubiquitination or involve calcium dependent proteolysis (Miyamoto et al., 1998) .
As has been previously documented, NF-kB proteins can act as survival factors by inhibiting apoptosis (Beg and Baltimore, 1996; Liu et al., 1996; Wang et al., 1996; Van Antwerp et al., 1996; Wu et al., 1996) . By inhibition of constitutive NF-kB activity via the expression of a dominant-negative IkBa mutant protein, we have shown that NF-kB is required for apoptosis resistance and proliferation of H-RS tumor cells (Bargou et al., 1997) . Furthermore, NF-kB is also needed as a survival factor in breast carcinoma cells and for proliferation and malignant transformation of thyroid carcinoma cells (Sovak et al., 1997; Visconti et al., 1997) , suggesting a more general role for nuclear NF-kB in human tumors (Gilmore, 1997) .
To understand the molecular basis underlying constitutive nuclear NF-kB activity in human tumor cells, the objective of this work was to analyse the mechanism leading to nuclear NF-kB activation in a panel of H-RS cells. We show that multiple mechanisms are responsible for active NF-kB in H-RS cells. Two H-RS cell lines, L428 and KMH-2, do not contain functional IkBa proteins. In contrast, three other H-RS cell lines, L591, L1236 and HDLM-2 express wild type IkBa. NF-kB DNA binding activity was still susceptible to inhibition by recombinant IkBa. Thus, the defect leading to constitutive NF-kB activation in these three cell lines seems to have been caused by deregulation of upstream regulatory pathways rather than defective NF-kB proteins. In accordance with this hypothesis we ®nd that IkBa is extremely unstable in L1236 and HDLM-2 cells, even though it is bound to p65. When IkBa degradation was blocked by inhibitors of the proteasomal NF-kB activating pathway, stabilization led to an accumulation of phosphorylated IkBa and to a reduction of NF-kB DNA binding activity. IkBa instability in H-RS cells correlated with constitutive activity of endogenous IKKs as determined in an in vitro kinase reaction after immunoprecipitation of IKKa. Furthermore, H-RS cells secrete one or more soluble factors that was able to activate NF-kB. Our data support the concept that H-RS cells have selected various defects in the homeostatic regulation of NF-kB. These defects result in growth advantage provided by the presence of nuclear p65 and c-Rel.
Results
Constitutive NF-kB activity correlates with defective IkBa in L428 and KMH-2 cells Constitutive nuclear NF-kB activity is observed in all tested Hodgkin/Reed-Sternberg cell lines as well as in primary H-RS cells isolated from a pericardial eusion (Bargou et al., 1996) . Furthermore, activated p65 has been detected in RS cells in lymph node sections of HD patients (Bargou et al., 1997) . High levels of constitutive NF-kB DNA binding activity were detected in whole cell extracts from ®ve dierent Figure 1 DNA binding activity and expression of NF-kB/IkB proteins in H-RS cells. (a) NF-kB DNA binding activity in whole cell lysates of H-RS and control cells (lanes 1 ± 10) was analysed by EMSA. The mobility of NF-kB heterodimers and of p50 homodimers is indicated. The subunit composition of constitutive NF-kB activity in L1236 cells was analysed by antibodysupershifting and -competition with antibodies directed against p50, p65 or c-Rel, as indicated (lanes 11 ± 14). (b) Steady-state amounts of IkBa, IkBb1 and p65 proteins were determined by Western blotting using speci®c antibodies, as indicated (see also Materials and methods). Speci®c protein bands and the mobility of molecular weight standards in kDa are indicated and the Cterminally truncated IkBa form in L428 cells (IkBaDC) is marked with a dot. Note, that the signal previously assigned to IkBa in KMH-2 cells appeared to be a non-speci®c cross-reaction of the polyclonal IkBa antibody with an unknown product (Bargou et al., 1996 ; data not shown) Hodgkin cell lines (Figure 1a) . In four of these cell lines (L428, L591, KMH-2 and HDLM-2) DNA binding activity has been shown to consist predominantly of heterodimers containing p65 and c-Rel (Bargou et al., 1996) . In addition, L1236 cells, established from the peripheral blood from a patient with advanced HD, have been analysed. This cell line is derived from H-RS cells of the patient, as has been shown previously by genotypic analysis . Like the other H-RS cell lines, L1236 cells displayed strong constitutive NF-kB activity. Besides the p50/p65 and p50/c-Rel heterodimers found in all tested H-RS cells, L1236 cells contained an enhanced DNA binding activity consisting of p50 homodimers, as determined by supershifting analysis (Figure 1a : lanes 11 ± 14). These ®ndings further support the concept that constitutive NF-kB activity is a general characteristic of H-RS cells.
In an attempt to clarify the mechanisms leading to constitutive NF-kB activity, we have analysed the levels of IkBa, IkBb and p65 in H-RS in comparison to several non-Hodgkin cell lines (Figure 1b ). Western blotting with antibodies directed either against the C-terminus or the N-terminus of IkBa revealed a speci®c band of the expected size for IkBa in HeLa, MCF7, Reh, Namalwa and Raji cells. Three H-RS cell lines, namely L591, L1236 and HDLM-2, also contained wild type IkBa (wtIkBa), even though HDLM-2 expressed only very small amounts of IkBa. No signal for wtIkBa was detected in L428 and KMH-2 cells. In L428 cells a faster migrating form was observed, using an IkBa antibody directed against the N-terminal part of the protein.
This band of about 30 kDa (IkBaDC) as well as the wtIkBa signal was speci®cally competed with the peptide used for immunization and therefore corresponds to a C-terminal truncation product. KMH-2 cells did not reveal any short form of IkBa under these conditions. All H-RS cell lines analysed contain high levels of a single IkBa mRNA (Bargou et al., 1996) . The IkBa cDNAs from each H-RS cell line analysed above were cloned and sequenced. Indeed, the IkBa cDNAs from L428 and KMH-2 cells contained point mutations leading to the generation of C-terminally truncated proteins (to be published elsewhere). Since in both cases the mutant IkBa proteins are too small to contain the complete ankyrin repeat domain, neither form of IkBa is able to block translocation and DNA binding activity of NF-kB (Hatada et al., 1993; Ernst et al., 1995; Rodriguez et al., 1995) . In contrast, no mutations leading to the expression of aberrant IkBa were detected in other H-RS cell lines (data not shown). Our data (Figure 1b ) suggest that defective IkBa can explain constitutive NF-kB activity in L428 and KMH-2 cells, but that mutations aecting IkBa are not a common feature of H-RS cells.
Western blotting using antibodies against IkBb1, IkBb2 (Hirano et al., 1998) or p65 did not show signi®cant alterations in the expression of these proteins ( Figure 1b ; data not shown), although some changes in the relative amounts of the IkB proteins could be detected. These minor dierences are not sucient to explain the high constitutive NF-kB DNA binding activity.
NF-kB activity in H-RS cells is not further enhanced by cellular stimulation but is susceptible to IkBa mediated inhibition
Due to the existence of wtIkBa in several H-RS cell lines, we wanted to test if stimulation with NF-kB activating agents might lead to further enhancement of NF-kB activity. H-RS as well as HeLa and Reh cells were stimulated with TNFa or PMA and NF-kB activity was measured by EMSA ( Figure 2a ). TNFa, and to a weaker extent PMA, led to an activation of NF-kB in HeLa and Reh cells. In contrast, no Figure 2 Complete activation of NF-kB in H-RS cells is observed in the absence of stimulation. H-RS cells (L428, L591, L1236, KMH-2 and HDLM-2; lanes 1 ± 15) and control cells (HeLa and Reh; lanes 16 ± 21) were either untreated or treated for 25 min with TNFa (25 ng/ml) or for 45 min with PMA (50 ng/ml). NF-kB DNA binding activity from whole cell extracts was determined by EMSA (a) and IkBa protein levels by Western blotting (b) using an antibody directed against an N-terminal epitope of the protein.
IkBaDC in L428 cells is marked with a dot additional activation was observed in H-RS cells either containing or lacking functional IkBa. Thus, maximal NF-kB induction was present even in the cell lines containing full length IkBa. A Western blot analysis of IkBa in L591, L1236 and HDLM-2 cells revealed that the inhibitor was only marginally aected in response to TNFa treatment ( Figure 2b ). In contrast, ecient IkBa degradation was seen after TNFa stimulation in HeLa or Reh cells.
To address the question whether mutations in the genes encoding NF-kB/Rel proteins or posttranslational modi®cations would prevent an interaction with IkBa in L591, L1236 or HDLM-2 cells, cellular extracts were incubated with increasing amounts of recombinant IkBa and subsequently NF-kB DNA binding activity was analysed by EMSA ( Figure 3 ). Comparable NF-kB DNA binding activities either from TNFa stimulated HeLa cells or from untreated H-RS cells were inhibited by equivalent amounts of recombinant IkBa (about 400 pg). Some residual NFkB DNA binding activity in L1236 and L591 cells (lanes 10 and 15) is presumably due to a dierent subunit composition of the NF-kB complexes in these cell lines compared to TNFa treated HeLa cells (data not shown). Clearly, NF-kB from H-RS cells is still able to interact with IkBa, as is also demonstrated by a co-precipitation analysis (see below). As expected, the increased p50/p50 DNA binding activity in L1236 cells was not aected by recombinant IkBa.
IkBa is associated with p65 and displays an enhanced turnover in HDLM-2 and L1236 cells Constitutive NF-kB activity in B cells correlates with an increased turnover of IkBa and IkBb (Rice and Ernst, 1993; Miyamoto et al., 1994 Miyamoto et al., , 1988 Krappmann and Scheidereit, 1997) . A pulse-chase analysis of Reh, HDLM-2 and L1236 cells was performed to investigate the stability of IkBa (Figure 4a ). IkBa from Reh cells exhibited a half-life of about 90 min. In contrast, IkBa turnover in HDLM-2 or L1236 cells was markedly increased. Already 22 min after removal of the labeling medium, IkBa was almost completely degraded. The kinetics of IkBa degradation in both H-RS cell lines were comparable to the kinetics of stimulus induced breakdown of IkBa in HeLa or Namalwa cells (Naumann and Scheidereit, 1994) , suggesting that the extremely short half-life of IkBa in H-RS cells results from continuous upstream signaling through NF-kB activating pathways. 5) or untreated H-RS cells (L1236, L591, and HDLM-2; lanes 6 ± 20) were incubated with increasing concentrations of recombinant IkBa (0, 50, 100, 400, or 1000 pg, respectively) for 30 min on ice and subsequently analysed for NF-kB DNA binding activity by EMSA. p50/p65 as well as p50/p50 DNA complexes are indicated Figure 4 IkBa is bound to p65 and displays a short half-life in H-RS cells. IkBa turnover in Reh (lanes 1 ± 6), HDLM-2 (lanes 7 ± 12) or L1236 cells (lanes 13 ± 18) was determined in a pulse-chase analysis. After removal of the labeling medium the chase was carried out for 0, 22, 45, 90 or 180 min. RIPA whole cell extracts were prepared and immunoprecipitated using IkBa C-21 antibody (a) or p65 A antibody (b). The speci®city of the immunoprecipitated bands was controlled by peptide competition (lanes 1, 7, 13) in which the speci®c peptide was included in the immunoprecipitation step. The mobility of the IkBa and p65 proteins and the molecular weight standards (in kDa) are indicated. Note that IkBa is speci®cally coprecipitated with p65 (b) and that a strong nonspeci®c signal in HDLM-2 cells (lanes 7 ± 12), which was seen in all immunoprecipitations, is running about 4 kDa above IkBa
Immunoprecipitations of p65 from Reh, HDLM-2 and L1236 cells showed that in all three cell lines IkBa was associated with p65 ( Figure 4b ). Coprecipitation of p65 and IkBa in vivo rules out that constitutive NF-kB activation results from mutations of IkBa or p65 proteins in HDLM-2 and L1236 cells, preventing their ability to interact and is consistent with the in vitro interaction shown in Figure 3 . Interestingly, comparable IkBa amounts from Reh, L1236 or HDLM-2 cells were precipitated with either anti-IkBa or anti-p65 antibodies, suggesting that most IkBa protein was complexed with p65. In the H-RS cells, IkBa bound to p65 was also degraded rapidly. In contrast to IkBa, p65 was very stable and its amount was not signi®cantly reduced during the time of the chase.
Instability of IkBa in H-RS cells can be blocked with ALLN or TPCK and stabilization leads to a reduction of NF-kB activity IkBa instability was also observed in H-RS cells that had been treated with cycloheximide (CHX), an inhibitor of protein biosynthesis (Figure 5a ). Addition of CHX led to a strong reduction of IkBa in HDLM-2 and L1236 cells already after 30 min, but only marginally aected IkBa amounts in Reh cells. Interestingly, IkBaDC in L428 cells was also rapidly degraded when protein biosynthesis was blocked. p65 levels were determined on the same blot after stripping. p65 amounts were not in¯uenced by the addition of cycloheximide which is consistent with its low turnover.
To investigate the mechanism responsible for the high turnover of IkBa in HDLM-2 and L1236 cells, protein biosynthesis was blocked in the presence of either ALLN or TPCK (Figure 5b ), both of which are known to inhibit signal induced degradation of IkBa and activation of NF-kB (Henkel et al., 1993; Traenckner et al., 1994; Krappmann et al., 1996) . In both cell lines degradation of IkBa was strongly inhibited by ALLN. In addition, a hyper-phosphorylated form of IkBa was detectable. In contrast, treatment with TPCK led to a stabilization but not to a phosphorylation of IkBa. These results are consistent with the notion that ALLN blocks proteasomal degradation of phosphorylated IkBa, whereas TPCK prevents signal induced phosphorylation of the inhibitor (Henkel et al., 1993; Krappmann et al., 1996) . The data thus suggest that NF-kB 12) and L1236 (lanes 13 ± 24) cells were incubated with ALLN (50 mg/ml; lanes 5 ± 7, 11 and 17 ± 19, 23) or TPCK (100 mM; lanes 8 ± 10, 12 and 20 ± 22, 24) for 20 min before the addition of cycloheximide (CHX; 25 mg/ml; lanes 2 ± 10 and 14 ± 22) for the indicated period of time. Western blotting was carried out as in a. The positions of IkBa, phosphorylated IkBa (IkBaP) and p65 are indicated activation in HDLM-2 and L1236 cells is due to continuous upstream signaling resulting in phosphorylation and subsequent degradation of IkBa.
To prove that enhanced degradation was responsible for NF-kB activation in HDLM-2 and L1236 cells, ALLN was added for a prolonged time. IkBa was analysed by Western blotting and NF-kB activity by EMSA ( Figure 6 ). As observed in the previous experiment, treatment with ALLN led to the appearance of phosphorylated IkBa in both HDLM-2 and L1236 cells (Figure 6a, lanes 5 ± 12) . A weak phosphorylation of IkBaDC was observed in L428 cells after the addition of ALLN (compare lanes 17 versus 18 and 19), which con®rms that phosphorylation depends on the presence of the N-terminal phosphorylation sites (Ser 32/36) and not on the constitutive phosphorylation within the C-terminal PEST region (Barroga et al., 1995) . In contrast, ALLN had no eect on the phosphorylation status of IkBa in Reh cells (lanes 1 ± 4) . The EMSA analysis shows a signi®cant reduction of NF-kB in HDLM-2 cells within 8 h of incubation with ALLN and a somewhat weaker reduction in L1236 cells. In contrast, NF-kB activity neither in KMH-2 nor in L428 cells was aected by ALLN. This is consistent with the model that the latter cell lines acquire NF-kB activation primarily through the lack of functional IkBa, whereas in HDLM-2 or L1236 cells activation is due to continuous signaling upstream of IkBa.
Instability of IkBa correlates with constitutive IKK activity in H-RS cells
Recently a kinase complex has been identi®ed that phosphorylates IkB proteins in response to cytokine signaling. The inducible proteinkinases IKKa and IKKb have been identi®ed as components of this high molecular weight complex (Maniatis, 1997; Stancovski and Baltimore, 1997) . To test whether IKK's contribute to constitutive NF-kB activity in H-RS cells we investigated the expression and activity of IKKa (Figure 7) . No changes in the expression of IKKa could be observed in H-RS cells compared to control cells (Figure 7a ). An in vitro kinase assay was performed to determine the activity of endogenous IKK's in H-RS cells (Figure 7b) . Three H-RS cell lines (HDLM-2, L1236 and KMH-2) and Namalwa B cells as a control cell line that lacks constitutive p50/ p65 complexes (data not shown) were either untreated or stimulated for 5 min with TNFa. Extracts were immunoprecipitated with IKKa antibody. After extensive washing the protein A-sepharose was taken up in kinase buer and incubated with 1 mg recombinant IkBa in the presence 3 mCi [g-32 P]ATP. The IKKa antibody speci®cally precipitated a kinase activity from Namalwa cell extracts that is activated in response to TNFa (compare lanes 1, 2 and 9, 10). Hyper-phosphorylation by IKK caused a reduced mobility of recombinant IkBa when compared to a non-speci®c phosphorylation that is also visible in the control precipitation (lanes 9, 10). IKKa immunoprecipitates phosphorylated IkBa at serine 32/36 as determined using an IkBa antibody that speci®cally recognizes only phosphorylated IkBa (data not shown). In vitro kinase reactions using IKKa precipitates from H-RS cells show hyper-phosphorylation of recombinant IkBa even in the absence of stimulation (lanes 3 ± 8). The extent of constitutive IkBa phosphorylation in HDLM-2 and KMH-2 cells was comparable to the induced phosphorylation in Namalwa cells and could not be further enhanced by the addition TNFa. Compared to HDLM-2 and Figure 6 Inhibition of the proteasome leads to an accumulation of phosphorylated IkBa in H-RS cells and to a reduction of NFkB DNA binding activity. Reh (lanes 1 ± 4), HDLM-2 (lanes 5 ± 8), L1236 (lanes 9 ± 12), KMH-2 (lanes 13 ± 16) or L428 cells (lanes 17 ± 19) were incubated for 0 to 8 h with the proteasomal inhibitor ALLN (50 mg/ml). (Hsu et al., 1989; Xerri et al., 1992; Foss et al., 1993; Wolf et al., 1996; Serano et al., 1997) . Some of these cytokines are potential activators of NF-kB or are regulated by NF-kB on the transcriptional level. To test whether activation of NF-kB can be induced by one or more soluble factor(s) that are secreted by H-RS cells, the pre-B cell line Reh, lacking constitutive NF-kB activity, was incubated with H-RS cell medium (Figure 8 ). Media taken from HDLM-2, L1236, or KMH-2 cells in fact caused NFkB activation within 30 min. NF-kB was only transiently activated in response to H-RS cell medium. No NF-kB activation was detectable when medium was taken from other cell lines (HeLa, MCF7, or Namalwa). These experiments illustrate that the production and secretion of one or more extracellular factor(s) by H-RS cells can trigger activation of NF-kB. As discussed below, we favor the hypothesis that constitutive NF-kB is caused by defects in either NF-kB homeostatic regulation or NF-kB stimulating pathways. Aberrant constitutive NF-kB in turn can trigger paracrine NF-kB activation via enhanced cytokine expression. Figure 8 H-RS cell lines secrete a soluble factor that activates NF-kB. Reh cells were pelleted by centrifugation and the medium was replaced either by fresh RPMI medium (lanes 1 ± 3) or by medium taken from HDLM-2 (lanes 4 ± 6), L1236 (lanes 7 ± 9), KMH-2 (lanes 10 ± 12), HeLa (lanes 13 ± 15), MCF7 (lanes 16 ± 18) or Namalwa (lanes 19 ± 21) cells. Cell cultures were grown for 48 h before removal of growth media by centrifugation. The Reh cells were kept in the growth media for the times indicated, whole cell lysates were prepared and analysed by EMSA. NF-kB DNA binding activity is indicated
Discussion
The dual requirement of NF-kB in H-RS cells for proliferation and for resistance towards apoptosis (Bargou et al., 1997) makes it crucial to understand the mechanism leading to constitutive NF-kB activity in these cells. We have investigated the components of the NF-kB/IkB signaling system in a panel of H-RS cell lines. Our data indicate that constitutive nuclear NF-kB activity cannot be explained by a single defect, that is common to all H-RS cells, but is rather a consequence of deregulation at dierent levels of the NF-kB regulatory network.
In agreement with a recent publication (Wood et al., 1998) , we did not detect full length IkBa protein in L428 or KMH-2 cells. Disruption of wild type IkBa (wtIkBa) expression in both cell lines resulted from point mutations, which cause expression of truncated IkBa (data not shown). Previous structure-function analysis predicts that neither the 30 kDa IkBaDC version in L428 cells nor the even shorter IkBa product in KMH-2 cells should be able to interact with NF-kB (Hatada et al., 1993; Ernst et al., 1995; Rodriguez et al., 1995) . Thus, L428 and KMH-2 cells contain a functionally inactive IkBa. Interestingly, IkBa`knockout' mice showed enhanced NF-kB activity only in cells of the haematopoietic lineage, suggesting that in contrast to other cell types none of the other IkB proteins is able to compensate for the loss of IkBa in B and T cells (Beg et al., 1995) . Since H-RS cells are derived from haematopoietic origin, IkBa could possibly be the critical inhibitor for NF-kB. No compensatory upregulation of IkBb1 or IkBb2 was observed in L428 or KMH-2 cells (Figure 1b and data not shown).
An analysis of a panel of cell lines derived from patients with HD revealed that aberrant IkBa is not generally found in H-RS cells. Previously, we demonstrated that HD-MyZ and L540 cells express full length IkBa (Bargou et al., 1997) . In this report we showed that L591, L1236 and HDLM-2 cells all contain wtIkBa protein. Consequently, in contrast to the conclusion drawn by Wood et al. (1998) other defects must account for NF-kB activation in the majority of H-RS cell lines analysed. Since stimulation with TNFa or PMA did not result in further enhancement of NF-kB DNA binding activity, it seems that NF-kB proteins are already in a maximal activated state. NF-kB activity is caused by full activation of the IKK complex (see also below) rather than by impaired IkB/NF-kB complex formation, because even short lived IkBa in H-RS cells was associated with p65. Interestingly, in addition to NFkB heterodimers, L1236 cells contain an increased binding activity of p50 homodimers. Activation of p50/ p50 complexes depends on processing of the p105 precursor and possibly on the nuclear IkB family member Bcl-3 (Watanabe et al., 1997) , indicating that further regulatory systems are defective in L1236 cells.
Since NF-kB activity could be inhibited by recombinant IkBa and because p65 is complexed with IkBa in vivo, it seems unlikely that mutations or posttranslational modi®cations of NF-kB lead to a release from the IkBs in H-RS cells. This is also supported by the ®nding that constitutive NF-kB activity can be suppressed by stable expression of a dominant-negative IkBa mutant in HDMyZ and L540 H-RS cells (Bargou et al., 1997) . In addition, most mutations of p65, which abolish an interaction with IkB proteins, would also aect dimerization and/or DNA binding of NF-kB and therefore cause an inactivation of its transcriptional activation potential (Beg et al., 1992; Ganchi et al., 1992) .
We investigated whether deregulation further upstream in the NF-kB/IkB signaling pathway might account for constitutive NF-kB activity. We found that IkBa in H-RS cells is rapidly degraded. In principle, two dierent mechanisms have been suggested to account for IkBa instability: (I) Signal induced degradation by numerous activators leads to a rapid depletion of cytoplasmic IkBa and involves phosphorylation at serine residues 32/36 and subsequent ubiquitination that targets the protein for proteasomal degradation Brown et al., 1995; Traenckner et al., 1995; Whiteside et al., 1995; Scherer et al., 1995) . (II) In contrast, IkBa turnover is a slower process that is independent on phosphorylation and ubiquitination in the N-terminal part of IkBa (Rice and Ernst, 1993; Krappmann et al., 1996; Miyamoto et al., 1998) . The degradation of IkBa in H-RS cells shows all the characteristics of the pathway controlling signal induced breakdown of IkBa as evidenced by its kinetics, the sensitivity towards TPCK or ALLN and the appearance of hyperphosphorylated IkBa intermediates. In addition, in the absence of stimulation, H-RS cells show an enhanced constitutive IKK activity, as demonstrated in kinase assays after immunoprecipitation using a monoclonal antibody against IKKa. Since IKKa amounts are not altered in H-RS cells, constitutive IKK activity is either due to deregulated upstream signaling or results from changes in the composition of the IKK complex. Potential candidates like IKKb and NEMO need to be investigated as soon as the appropriate tools are available (Yamaoka et al., 1998) . Also mutations of the components of the kinase complex might cause hyper-activity of the IKKs. Such changes might not necessarily be detectable in a Western blot.
NF-kB DNA binding activity was reduced in two IkBa containing cell lines (HDLM-2 and L1236) after inhibition of the proteasomal degradation machinery with ALLN ( Figure 6 ). In contrast to this experiment, Wood et al. (1998) did not observe any eect of the proteasomal inhibitor ZLLLH on NF-kB DNA binding activity in HDLM-2 cells. This discrepancy might result from dierent experimental conditions. A signi®cant eect on NF-kB activity was only visible after prolonged treatment with the proteasomal inhibitor ALLN. Nevertheless, the reduction of NFkB DNA binding activity was speci®c, because it was restricted to wtIkBa containing H-RS cells. Thus, in two H-RS cell lines, we ®nd no evidence for functionally defective IkBa as suggested by Wood et al. (1998) . We propose, that in IkBa containing H-RS cells NF-kB activation is an eect of deregulated upstream signaling rather than defective IkBa proteins.
H-RS cells are known to produce and secrete in¯ammatory cytokines including such that are potentially able to activate NF-kB or which are transcriptionally regulated by NF-kB (Hsu et al., 1989 Ghoda et al., 1997; Yamaoka et al., 1998) might have acquired gain or loss of function mutations, respectively. In addition, further mutations or modi®cations in IkBb or IkBe might be responsible for NFkB activation. Nevertheless, deregulated cytokine secretion is relevant for the clinical manifestation of HD. It will be interesting to determine in how far active NF-kB is needed for the production of in¯ammatory cytokines by H-RS cells.
The results presented here demonstrate that multiple defects contribute to aberrant constitutive NF-kB in H-RS cells. Since NF-kB protects against apoptosis and stimulates proliferation in H-RS cells, there seems to be a selective pressure for the accumulation of mutations that speci®cally lead to NF-kB activation. Identification of the aected upstream components in H-RS cells will be a further important step. In order to attain a more solid understanding about the molecular aspects of the pathogenesis of HD, further studies will have to determine the contribution of the defective NF-kB regulatory system in primary material derived from the patients.
Materials and methods

Cell culture
L428, L591, L1236, KMH-2 and HDLM-2 as well as Reh, Namalwa and Raji cells were grown in RPMI 1640 (Gibco), supplemented with 10% fetal calf serum (FCS) and 2 mM L-glutamine. HeLa and MCF7 cells were grown in DMEM (Gibco), supplemented with 10% FCS, and 1 mM sodium pyruvate. All media contained 100 U/ml penicillin/streptomycin. Cells were treated with the following agents: 25 ng/ml TNFa (Calbiochem), 50 nM 4b-phorbol-12-myristate-13-acetate (PMA; Sigma), 50 mg/ml N-acetyl-leucyl-leucyl-norleucinal (ALLN; Calbiochem), 25 mg/ml cycloheximide (CHX; Calbiochem), and 100 mM tosyl-phe-chloromethylketone (TPCK; Sigma).
Electrophoretic mobility shift assay (EMSA) and Western blotting
Whole cell extracts were prepared essentially as described previously (Wulczyn et al., 1998) . After washing the cells with PBS, lysis buer (20 mM HEPES pH 7.9, 350 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 1 mM MgCl 2 , 10% Glycerol, 1% Nonident P-40, 1 mg/ml Pefabloc, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A, 10 mM NaF, 8 mM b-glycerophosphate and 1 mM DTT) was added and after 10 min incubation at 48C the lysate was centrifuged for 5 min at 14 000 r.p.m. in a microfuge.
Electrophoretic mobility shift assays (EMSA) were performed as described in Naumann et al. (1993) . Western blots were analysed by chemiluminescence following the manufacturer's recommendations (New England Biolabs). The following antibodies (Santa Cruz) were used: IkBa C-21, directed against the C-terminal part of the protein; IkBa C-15, directed against an N-terminal epitope; IkBb C-20; p65 (A); cRel (C). Monoclonal IKKa antibody (B78-1) was obtained from Pharmingen.
Metabolic labeling and immunoprecipitation
For metabolic labeling, cells were washed with EMEM free of methionine (ICN), supplemented with 10% dialyzed FCS (Gibco) and 2 mM glutamine and kept in this medium for 30 min before adding 35 [S]-methionine (100 mCi/ml; 5610 6 cells/ml for each time point). After 60 min of incubation the 35 [S]-methionine-containing medium was removed and replaced by RPMI (10% FCS). Extracts were prepared at the indicated time points. The cells were washed twice with PBS and lysed in RIPA-buer (50 mM Tris [pH 8], 150 mM NaCl, 1% Nonident P-40, 0.5% DOC, 0.1% SDS, 1 mg/ml Pefabloc, 1 mg/ml aprotinin, 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 10 mM NaF, 8 mM bglycerophosphate, and 1 mM DTT). After 20 min at 48C the extracts were centrifuged for 5 min in an microfuge at 14 000 r.p.m. The supernatant was used for immunoprecipitation. The extracts were ®rst precleared with 20 ml protein A-sepharose for 1 h at 48C. IkBa C-21 or p65 A antibodies (5 ml) and 10 ml protein A-sepharose were added and incubated at 48C for 3 ± 4 h. For each time point, protein extract from 1.5610 6 cells was prepared and used for immunoprecipitation. Protein A-sepharose was washed four times with ice-cold RIPA buer and boiled for 5 min in SDS-loading buer. The supernatant was applied to SDS ± PAGE followed by autoradiography.
IkB kinase assay
To assay IkB kinase activity the cells were either untreated or stimulated for 5 min with TNFa. After PBS washing extracts were prepared using lysis buer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1% Triton X-100, 10% glycerol, 1 mg/ml Pefabloc, 1 mg/ml aprotinin, 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 10 mM NaF, 8 mM b-glycerophosphate, 100 mM sodium orthovanadate and 1 mM DTT). 100 mg of each extract was used for immunoprecipitation which was performed in lysis buer including 250 mM NaCl.
Extracts were ®rst precleared with protein A-sepharose beads for 1 h at 48C. Immunoprecipitation using 1 mg monoclonal IKKa antibody (Pharmingen) was carried out for 2 h at 48C. The Protein A-sepharose was washed ®ve times with lysis buer including 250 mM NaCl and once with kinase buer (20 mM HEPES [pH 7.5], 10 mM MgCl2, 20 mM ATP, 20 mM b-glycerophosphate, 10 mM p-NPP, 50 mM sodium orthovanadate, 1 mM DTT). 20 ml of kinase buer including 1 mg puri®ed recombinant IkBa and 3 mCi [g-32 P]ATP were added to the protein A-sepharose immunecomplex and the kinase reaction was incubated for 20 min at 378C. Reaction mixtures were boiled and subjected to SDS ± PAGE and autoradiography.
